Board Member
Alaunos Therapeutics, Inc. (TCRT)Equibles does not estimate personal net worth.
Get an email with a short summary when Alaunos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TCRT alertsHeidi Hagen is recorded as Board Member at Alaunos Therapeutics, Inc. (TCRT) since May 19, 2021 and CEO at Alaunos Therapeutics, Inc. (TCRT). The newest filing on record that lists Heidi Hagen as CEO at Alaunos Therapeutics, Inc. (TCRT) is dated April 7, 2021. The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $2,730,871 for Heidi Hagen in fiscal 2021, including a base salary of $306,947. Disclosed compensation is on record for 2 fiscal years. Heidi Hagen has spoken on 3 earnings calls across 1 company, most recently for Alaunos Therapeutics, Inc. on August 9, 2021. Alaunos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alaunos Therapeutics, Inc. includes Dale Curtis Hogue, Jr. (CEO and Board Member), Holger Weis (CEO, Chairman and Board Member), Kevin Boyle (CEO and Board Member) and 7 others.
“Let me start by saying that I'm excited by the progress we have made across multiple fronts since our last call in May. Indeed, since the beginning of the year, we have truly transformed the company, and you can see the progress reflected on Slide 4 of the deck we posted.”
“I am pleased to provide an update on our progress this quarter. The first quarter was one of focus and execution as we emphasized building shareholder value over the long term.”
“Let me echo your thanks to Laurence and add a personal reflection before turning to a business overview. I have known Laurence for some years now and I'm honored to call him a colleague and friend.”
2021-05-19–present
Start not stated–present
Last confirmed April 7, 2021
2019-01-01–2021-11-02
Biotechnology · Healthcare
CEO, Board Member
2019-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Alaunos Therapeutics, Inc. (TCRT) | Former Interim Chief Executive Officer | $306,947 | $2,730,871 |
| 2020 | Alaunos Therapeutics, Inc. (TCRT) | Former Interim Chief Executive Officer | — | — |
